Startseite NSAIDs in postoperative pain
Artikel Öffentlich zugänglich

NSAIDs in postoperative pain

  • Vesa Kontinen
Veröffentlicht/Copyright: 1. Juli 2012
Veröffentlichen auch Sie bei De Gruyter Brill

The objectives of this presentation are to give an update on clinical pharmacology of non-steroidal anti-inflammatory analgesics (NSAIDs) in management of postoperative pain and discuss use of these drugs in specific patient groups.

Prostaglandins play important roles in many cellular responses and pathophysiologic processes including modulation of the inflammatory reaction, turnover of cartilage and bone, gastrointestinal cytoprotection, angiogenesis and cancer, hemostasis and thrombosis, and renal hemodynamics. The major target for NSAIDs is the cyclo-oxygenase pathway in the peripheral tissues. NSAIDs have also central actions in the spinal cord and brain. The relative contribution of peripheral and central sites of action is variable in different pain states is not complitely understood. It has been suggested that pharmacokinetic factors, such as the relative distribution to effect sites and sites where COX-inhibition is harmful (eg kidney), might partly explain differences in the efficacy and safety between various NSAIDs.

NSAIDs are effective analgesics in acute postoperative pain, especially when there is an inflammatory component. In severe postoperative pain it is not possible to study the effect of NSAIDs alone, but most commonly the opioid-sparing effect is studied, despite the shortfalls of the method. NSAIDs have been shown to relatively consistently reduce postoperative opioid consumption in average by 30–50%, and to reduce opioid-induced adverse effects, such as nausea & vomiting and sedation.

NSAIDs and coxibs have deleterious effect on renal function that can lead to both acute and chronic renal failure. The risk of acute renal failure associated to NSAID is increased in patients with hypertension, diabetes, and pre-existing renal diseases, including previous episodes of acute renal failure, exposure to other nephrotoxic drugs and contrast media, and the length of use. In patients with previously normal renal function and no perioperative problems with homeostasis, of NSAIDs for postoperative pain can be relatively safe to kidneys.

COX-1 has a key role in production of gastroprotective prostaglandins, and NSAIDs produce dyspepsia and peptic ulcer disease in chronic use. Coxibs are not completely devoid of adverse gastrointestinal effects, but the risk is significantly lower. In acute postoperative pain NSAIDs are usually used for a short period, and the risk of gastrointestinal problems is lower than in chronic use.

NSAIDs can lead to the development of congestive heart failure in susceptible individuals, but there are only few epidemiological investigations on this “forgotten” adverse effect. Since 2004 a lot has been written on thrombotic cardiovascular events associated to coxibs. In postoperative pain, NSAIDs or coxibs are in most cases used for a relatively short time, and therefore the cardiovascular risk profile is different from that in chronic use. Other risk factors for cardiovascular disease are importan for risk assessment for postoperative analgesia. NSAIDs (except ASA) reversibly inhibit COX-1 in platelets, and the effect on platelet aggregation and risk of bleeding is dependent on the half-life of the compound.

Prostaglandins are important in the regulation of osteoblast and osteoclast functions, and inhibition of prostaglandin production affect bone formation. COX-2 controls osteoclastogenesis, mechanotransduction, bone formation and fracture repair constitutively in the skeleton. Reports of impaired bone healing associated with NSAID treatment have therefore raised a concern, but here are no good clinical studies on this matter. Based on the importance of inflammation of the tissue healing in general, concern on the effect of NSAIDs on healing of surgical injury in other tissues, such as intestinal anastomoses, has also been raised. However, there is very little clinical evidence on this.

When considering the use of NSAIDs in postoperative pain, the analgesic good efficacy must be balanced against the known and assumed adverse effects. The assessment must be based on the individual characteristics of each patient, and compared to the risk profile of alternative methods of pain management.

Published Online: 2012-07-01
Published in Print: 2012-07-01

© 2012 Scandinavian Association for the Study of Pain

Artikel in diesem Heft

  1. Editorial comment
  2. Spontaneous pain is reduced by conditioning pain modulation in peripheral neuropathy but not in fibromyalgia—Implications for different pain mechanisms
  3. Clinical pain research
  4. Differential pain modulation in patients with peripheral neuropathic pain and fibromyalgia
  5. Editorial comment
  6. Pulsed radiofrequency—Time for a clinical pause and more science
  7. Clinical pain research
  8. Pulsed radiofrequency in peripheral posttraumatic neuropathic pain: A double blind sham controlled randomized clinical trial
  9. Editorial comment
  10. Phantom pains and sensations – how does it feel? Only the patient really knows
  11. Clinical pain research
  12. Phantom phenomena – Their perceived qualities and consequences from the patient’s perspective
  13. Editorial comment
  14. Impact of mental stressor on conditioned pain modulation
  15. Original experimental
  16. The effect of a mental stressor on conditioned pain modulation in healthy subjects
  17. Editorial comment
  18. Pharmacological modulation of chronic pain after whiplash injury
  19. Clinical pain research
  20. Whiplash Associated Disorders (WAD): Responses to pharmacological challenges and psychometric tests
  21. Editorial comment
  22. Why are autonomic responses to pressure pain different from those to heat pain and ischaemic pain?
  23. Original experimental
  24. Cardiovascular responses to and modulation of pressure pain sensitivity in normotensive, pain-free women
  25. Correspondence
  26. Piriformis muscle injection guided by sciatic nerve stimulation: Quick, simple, and safe technique
  27. Correspondence
  28. Musculus piriformis syndrome: Localization and injection therapy—Comment to letter from Mayo-Moldes M et al. [1]
  29. Abstracts
  30. The “pain matrix” reloaded
  31. Abstracts
  32. Endpoints in animal pain models
  33. Abstracts
  34. Evaluating pain-related behavior in spinal cord injury
  35. Abstracts
  36. The role of the amygdala in sensory and emotional-like pain behavior in neuropathic animals
  37. Abstracts
  38. Peripheral and central pain mechanisms—From animal models to clinical research
  39. Abstracts
  40. Human experimental models of central sensitization—Do they bridge the gap between animal models and clinical observations?
  41. Abstracts
  42. Assessment of central sensitization in the clinic. Is it possible?
  43. Abstracts
  44. Migraine neurobiology and treatment
  45. Abstracts
  46. Chronic headaches–Goals and obstacles
  47. Abstracts
  48. Trigeminal neuralgia and other cranial neuralgias
  49. Abstracts
  50. Temporomandibular disorders: Pathophysiology and diagnosis
  51. Abstracts
  52. HIV-associated painful polyneuropathy
  53. Abstracts
  54. Keynote: Neuronal and glial signalling in pain neuroplasticity
  55. Abstracts
  56. Neuropathic pain—From guidelines to clinical practice
  57. Abstracts
  58. Postoperative pain treatment. What’s the evidence—And how to use it?
  59. Abstracts
  60. NSAIDs in postoperative pain
  61. Abstracts
  62. How should we prevent persistent postoperative pain?
  63. Abstracts
  64. Opioids: Genetics and receptors
  65. Abstracts
  66. Chronic pain and sleep disorders
  67. Abstracts
  68. Population-based studies on chronic pain: The role of opioids
  69. Abstracts
  70. Living beyond pain: Acceptance and commitment therapy
  71. Abstracts
  72. Modality specific alterations of esophageal sensitivity caused by longstanding diabetes mellitus
  73. Abstracts
  74. Validation of a porcine behavioural model of UVB induced inflammatory pain
  75. Abstracts
  76. Recovery after a lumbar disc herniation is dependent on a gender and OPRM1 Asn40Asp genotype interaction
  77. Abstracts
  78. Pain sensitivity changes in chronic pain patients with and without spinal cord stimulation assessed by nociceptive withdrawal reflex thresholds and electrical pain thresholds
  79. Abstracts
  80. Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial
  81. Abstracts
  82. Sortilins in neuropathic pain
  83. Abstracts
  84. Systematic review of neuropathic component in persistent post-surgical pain
  85. Abstracts
  86. Pain prevalence in a university hospital in Iceland
  87. Abstracts
  88. The effect of tail-docking neonate piglets on ATF-3 and NR2B immunoreactivity in coccygeal dorsal root ganglia and spinal cord dorsal horn neurons: Preliminary data
  89. Abstracts
  90. Na+/K+-ATPase dependent regulation of astrocyte Ca2+ signalling: A novel mechanism for modulation of long-term pain?
  91. Abstracts
  92. Glutamate attenuates nitric oxide release from isolated trigeminal ganglion satellite glial cells
  93. Abstracts
  94. Acute behavioural responses to tail docking in piglets – Effects of increasing docking length?
  95. Abstracts
  96. Dose and administration-period play a key role in the effect of ceftriaxone on neuropathic pain in CCI-operated rats
  97. Abstracts
  98. Translational aspects of rectal evoked potentials: A comparative study in rats and humans
  99. Abstracts
  100. Time-course of analgesic effects of botulinum neurotoxin type A (BoNTA) on human experimental model of pain induced by injection of glutamate into temporalis muscle
  101. Abstracts
  102. The effect of nerve compression and capsaicin on contact heat evoked potentials (CHEPs) related to Aδ and C fibers
  103. Abstracts
  104. Effect of specific trapezius exercises vs. coordination training on corticomotor control of neck muscles
  105. Abstracts
  106. SNP in TNFα T308G is predictive for persistent postoperative pain following inguinal hernia surgery
  107. Abstracts
  108. Chronic pain in thoracotomy
  109. Abstracts
  110. The variability in thermal threshold-assessments in post-thoracotomy pain syndrome
  111. Abstracts
  112. Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer
  113. Abstracts
  114. Neuroplastic alterations in brain responses to painful visceral stimulations reflects individual neuropathic symptoms in diabetes mellitus patients
  115. Abstracts
  116. Exercise and conditioned pain modulation have different effects on cuff pressure pain tolerance in humans
  117. Abstracts
  118. Hyperalgesia in human skin and deep-tissues inside and outside of a UVB irradiated area
  119. Abstracts
  120. Effect of experimental jaw muscle pain on bite force during mastication
  121. Abstracts
  122. Reflex threshold assessment methodology for evaluation of central sensitisation is vulnerable to EMG crosstalk
  123. Abstracts
  124. Cognitive modulation of experimental pain at spinal and cortical levels
  125. Abstracts
  126. Influence of emotionally loaded visual and gustatory stimuli on pain perception
  127. Abstracts
  128. Modulating pain with augmented reality
  129. Abstracts
  130. Offset analgesia: A reproducibility study
  131. Abstracts
  132. Visualization of painful process in peripheral tissue using positron emission tomography and [11C]-D-deprenyl
  133. Abstracts
  134. Mirror-image sensory dysfunction in the post-thoracotomy pain syndrome
  135. Abstracts
  136. Genetic variation in opioid receptor genes and sensitivity to experimental pain in male and female healthy volunteers
  137. Abstracts
  138. Mechanical sensitivity in migraine patients during attack, remission, and pain-free periods:A preliminary study
  139. Abstracts
  140. Multivariate pattern analysis of evoked brain potentials by temporal matching pursuit and support vector machine
  141. Abstracts
  142. Pain following stroke: A prospective study
  143. Abstracts
  144. Chronic thoracic pain in children after cardiac surgery
  145. Abstracts
  146. Chronic pain after breast augmentation is associated with both signs of peripheral nerve injury and central nervous mechanisms
  147. Abstracts
  148. Sensory phenotypes in patients with peripheral neuropathic pain evaluated with quantitative sensory testing
  149. Abstracts
  150. Is health related quality of life related to the pattern of chronic pain?
  151. Abstracts
  152. Comparison between ropivacaine local infiltration analgesia with ketorolac or placebo for total knee replacement surgery
  153. Abstracts
  154. Treatment with topical capsaicin: Experience from a pain clinic
  155. Abstracts
  156. Distribution of concussion related symptoms after whiplash injury in risk strata
  157. Abstracts
  158. HIV/AIDS in different cultures
  159. Abstracts
  160. Pain perception is altered in patients with medication-overuse headache but can improve after detoxification
  161. Abstracts
  162. Detoxification in a structured programme is effective for medication-overuse headache
Heruntergeladen am 20.10.2025 von https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2012.05.017/html
Button zum nach oben scrollen